drugset
drugset / Trial / NCT03657810

A Controlled Study to Determine the Efficacy and Safety of CL-108 5 mg for Acute Pain and the Prevention of OINV

NCT03657810 ↗

Phase 3 Completed 349 enrolled Charleston Laboratories, Inc
RandomizedParallel-groupDouble-blindTreatment

Summary

To determine the analgesic efficacy of CL-108 5 mg by comparison with placebo and the anti-emetic efficacy of CL-108 5 mg by comparison with hydrocodone 5 mg/acetaminophen 325 mg.

Timeline

Start
2017-08-02
Primary completion
2018-04-16
Completion
2018-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 325 mg —
Subject Hydrocodone Unknown 5 mg —
Subject Promethazine Small molecule 12.5 mg —

Indications

No indication recorded.